Delve into how the biotech industry is pivoting from the amyloid hypothesis to find new Alzheimer's disease treatments.

A recent study revealed that an experimental blood test for Alzheimer’s disease not only can help in accurate diagnosis but ...

There's still so much we don't know about Alzheimer's disease, but the link between poor sleep and worsening disease is one ...

Roche Holdings AG (OTC:RHHBY) on Thursday presented new data at the AD/PD 2025 International Conference on Alzheimer’s and ...

Roche has reported preliminary results on its Alzheimer’s disease prospect trontinemab. | Roche has reported preliminary ...

Alzheimer's disease is one of the world’s most prevalent brain disorders, being extremely difficult to treat. Alzheimer's ...

“This blood test clearly identifies Alzheimer’s tau tangles, which is our best biomarker measure of Alzheimer’s symptoms and ...

Encouraging interim results have supported Roche’s decision to move trontinemab into a pivotal Phase III programme.

Researchers have developed a blood test based on a protein biomarker for tau tangles that can help diagnose Alzheimer’s ...

A study published in Brain Communications revealed new insights into early detection of Alzheimer’s disease. Researchers have ...